DTcP
- Generic Name
- DTcP
A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
Phase 3
Active, not recruiting
- Conditions
- Diphtheria, Tetanus and Acellular Pertussis
- Interventions
- Biological: Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)Biological: Diphtheria，Tetanus and Acellular Pertussis Combined Vaccine，DTaPBiological: Diphtheria,tetanus,pertussis(acellular,component),Inactivated polio vaccine(adsorbed）and Haemophilus influenzae type b conjugate vaccine,adsorbed,DTaP-IPV-Hib
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- CanSino Biologics Inc.
- Target Recruit Count
- 2520
- Registration Number
- NCT05951725
- Locations
- 🇨🇳
Changge Center for Disease Control and Prevention, Xuchang, Henan, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath